|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/351 |
| (11) | Patento numeris | 3057585 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14853953.9 |
| Europos patento paraiškos padavimo data | 2014-10-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-08-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/060477 |
| Data | 2014-10-14 |
| (87) | Numeris | WO 2015/057699 |
| Data | 2015-04-23 |
| (30) | Numeris | Data | Šalis |
| 201361891320 P | 2013-10-15 | US | |
| 201461941904 P | 2014-02-19 | US | |
| 201461947742 P | 2014-03-04 | US | |
| 201461975318 P | 2014-04-04 | US |
| (72) |
LYON, Robert, US
BURKE, Patrick, US
HUNTER, Joshua, US
|
| (73) |
Seagen Inc.,
21823 30th Drive, S.E., Bothell, WA 98021,
US
|
| (54) | PEGYLATED DRUG-LINKERS FOR IMPROVED LIGAND-DRUG CONJUGATE PHARMACOKINETICS |
| PEGYLATED DRUG-LINKERS FOR IMPROVED LIGAND-DRUG CONJUGATE PHARMACOKINETICS |